Volume 18, Number 2—February 2012
Letter
Human and Porcine Hepatitis E Viruses, Southeastern Bolivia
Table
Model | Start position | Stop position | Bolivia sequence | GenBank sequence | Mean tMRCA, y | 95% HPD, y |
Mean ± SD rate of substitutions/site/y | |
---|---|---|---|---|---|---|---|---|
Lower | Upper | |||||||
A | 826 | 1173 | X | NU | 55.31 | 16.26 | 108.05 | 3.27 × 10–3 ± 9.44 × 10–6 |
B | 826 | 1173 | NU | 3i and 3e | 148.63 | 3.01 | 291.46 | 1.88 × 10–2 ± 6.41 × 10–4 |
C | 826 | 1173 | X | X | 144.45 | 38.66 | 298.20 | 3.43 × 10–3 ± 4.74 × 10–5 |
D | 826 | 1173 | NU | X | 328.05 | 45.59 | 681.90 | 2.12 × 10–3 ± 7.33 × 10–5 |
E | 1 | 1980 | NU | X | 296.06 | 163.40 | 467.97 | 9.27 × 10–4 ± 1.25 × 10–5 |
F | 826 | 1173 | 3 seqs | X | 275.45 | 40.06 | 635.32 | 2.40 × 10–3 ± 5.06 × 10–5 |
*HEV, hepatitis E virus; ORF, open reading frame; tMRCA, time to the most recent common ancestor; HPD, highest posterior density boundary; X, sequences was used; NU, not used; 3i and 3e, subtype 3i and 3e sequences were used; 3 seqs, sequences (CV2, CB9, and HB2BA053) from Bolivia were used.
Page created: January 18, 2012
Page updated: January 18, 2012
Page reviewed: January 18, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.